151 related articles for article (PubMed ID: 1606772)
1. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
Murphy BF; McDonald I; Fairley KF; Kincaid-Smith PS
Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
[TBL] [Abstract][Full Text] [Related]
3. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[TBL] [Abstract][Full Text] [Related]
4. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG; Yu SH; Owen JE; Kincaid-Smith P
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[TBL] [Abstract][Full Text] [Related]
5. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.
Cameron JS; Healy MJ; Adu D
Q J Med; 1990 Feb; 74(274):133-56. PubMed ID: 2189149
[TBL] [Abstract][Full Text] [Related]
6. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
[TBL] [Abstract][Full Text] [Related]
8. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT; Lee GS; Lau YK; Chiang GS; Lim CH
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
11. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
12. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
15. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
Murphy BF; Fairley KF; Kincaid-Smith PS
Clin Nephrol; 1988 Oct; 30(4):175-81. PubMed ID: 3214963
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
Kibriya MG; Tishkov I; Nikolov D
Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328
[TBL] [Abstract][Full Text] [Related]
20. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]